PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Urofollitropin
Presentation Product Chemical substance Chapter Items dispensed
Bravelle 75unit inj vials
0605010M0BHAAAE
Bravelle Urofollitropin Endocrine System No data available
Fostimon 150unit inj vials
0605010M0BGABAF
Fostimon Urofollitropin Endocrine System No data available
Fostimon 75unit inj vials
0605010M0BGAAAE
Fostimon Urofollitropin Endocrine System No data available
Metrodin High Purity 150unit inj ampoules
0605010M0BDACAD
Metrodin Urofollitropin Endocrine System No data available
Metrodin High Purity 75unit inj ampoules
0605010M0BDABAC
Metrodin Urofollitropin Endocrine System No data available
Urofollitropin 150unit inj ampoules
0605010M0AAADAD
Urofollitropin Urofollitropin Endocrine System No data available
Urofollitropin 150unit inj vials
0605010M0AAAFAF
Urofollitropin Urofollitropin Endocrine System No data available
Urofollitropin 75unit inj ampoules
0605010M0AAACAC
Urofollitropin Urofollitropin Endocrine System No data available
Urofollitropin 75unit inj vials
0605010M0AAAEAE
Urofollitropin Urofollitropin Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.